These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25151112)

  • 1. The δ latent dementia phenotype in the uniform data set: Cross-validation and extension.
    Gavett BE; Vudy V; Jeffrey M; John SE; Gurnani AS; Adams JW
    Neuropsychology; 2015 May; 29(3):344-52. PubMed ID: 25151112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future Dementia Severity is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope.
    Palmer RF; Royall DR
    J Alzheimers Dis; 2016; 49(2):521-9. PubMed ID: 26444763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.
    O'Bryant SE; Lacritz LH; Hall J; Waring SC; Chan W; Khodr ZG; Massman PJ; Hobson V; Cullum CM
    Arch Neurol; 2010 Jun; 67(6):746-9. PubMed ID: 20558394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric Properties of the Clinical Dementia Rating - Sum of Boxes and Other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population.
    McDougall F; Edgar C; Mertes M; Delmar P; Fontoura P; Abi-Saab D; Lansdall CJ; Boada M; Doody R
    J Prev Alzheimers Dis; 2021; 8(2):151-160. PubMed ID: 33569561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.
    O'Bryant SE; Waring SC; Cullum CM; Hall J; Lacritz L; Massman PJ; Lupo PJ; Reisch JS; Doody R;
    Arch Neurol; 2008 Aug; 65(8):1091-5. PubMed ID: 18695059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Adiponectin is Related to Dementia.
    Benavente KSK; Palmer RF; Royall DR
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):779-783. PubMed ID: 31112230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Latent Construct for Dementia in a Population-Wide Dataset from Singapore.
    Peh CX; Abdin E; Vaingankar JA; Verma S; Chua BY; Sagayadevan V; Seow E; Zhang Y; Shahwan S; Ng LL; Prince M; Chong SA; Subramaniam M
    J Alzheimers Dis; 2017; 55(2):823-833. PubMed ID: 27802230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
    Monsell SE; Liu D; Weintraub S; Kukull WA
    Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview.
    Okereke OI; Copeland M; Hyman BT; Wanggaard T; Albert MS; Blacker D
    Arch Neurol; 2011 Mar; 68(3):343-50. PubMed ID: 21403019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
    Gavett BE; John SE; Gurnani AS; Bussell CA; Saurman JL
    J Alzheimers Dis; 2016; 49(2):531-45. PubMed ID: 26444761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing cognition and daily function in early dementia using the cognitive-functional composite: findings from the Catch-Cog study cohort.
    Jutten RJ; Harrison JE; Lee Meeuw Kjoe PR; Ingala S; Vreeswijk R; van Deelen RAJ; de Jong FJ; Opmeer EM; Aleman A; Ritchie CW; Scheltens P; Sikkes SAM
    Alzheimers Res Ther; 2019 May; 11(1):45. PubMed ID: 31092277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy-Based Evidence for Loss of Thinking Abilities (DELTA): Development and Validation of a Novel Approach to Identifying Cognitive Changes.
    Asken BM; Thomas KR; Lee A; Davis JD; Malloy PF; Salloway SP; Correia S
    J Int Neuropsychol Soc; 2020 May; 26(5):464-479. PubMed ID: 31822312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes in cognition in Parkinson's disease with and without dementia.
    Johnson DK; Galvin JE
    Dement Geriatr Cogn Disord; 2011; 31(2):98-108. PubMed ID: 21242691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    Koppara A; Wolfsgruber S; Kleineidam L; Schmidtke K; Frölich L; Kurz A; Schulz S; Hampel H; Heuser I; Peters O; Reischies FM; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Pantel J; Rienhoff O; Rüther E; Henn F; Wiltfang J; Maier W; Jessen F; Kornhuber J; Wagner M
    J Alzheimers Dis; 2016; 49(2):547-60. PubMed ID: 26484902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a Potential Telephone Assessment of Dementia Prevalence and Severity.
    Royall DR; Palmer RF
    J Neuropsychiatry Clin Neurosci; 2018; 30(3):202-207. PubMed ID: 29458281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired physical performance and the assessment of dementia of the Alzheimer type.
    Shah KR; Carr D; Roe CM; Miller JP; Coats M; Morris JC
    Alzheimer Dis Assoc Disord; 2004; 18(3):112-9. PubMed ID: 15494615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician's Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence based on Individual Participant Data from Five Randomized Clinical Trials of Donepezil.
    Samara M; Levine SZ; Yoshida K; Goldberg Y; Cipriani A; Efthimiou O; Iwatsubo T; Leucht S; Furakawa TA
    J Alzheimers Dis; 2021; 82(3):1075-1084. PubMed ID: 34120898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores.
    Williams MM; Storandt M; Roe CM; Morris JC
    Alzheimers Dement; 2013 Feb; 9(1 Suppl):S39-44. PubMed ID: 22858530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the validity of the clinical Dementia Rating Scale: the CERAD experience. Consortium to Establish a Registry for Alzheimer's Disease.
    Fillenbaum GG; Peterson B; Morris JC
    Aging (Milano); 1996 Dec; 8(6):379-85. PubMed ID: 9061124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.